1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

02 Aug 2024
Admin
News Article

GC Biopharma Selects KabaFusion as a Distribution Partner to Provide Alyglo

GC Biopharma selects KabaFusion as a distribution partner to provide Alyglo for adults with primary humoral immunodeficiency

Overview

KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA as a limited distribution partner to provide Alyglo (Immune Globulin Intravenous, Human-stwk) 10 per cent liquid for adults, 17 years and older, with primary humoral immunodeficiency (PI).

About Alyglo

Alyglo is a liquid solution containing 10 per cent immunoglobulin G (100 mg/mL) for intravenous infusion.
Alyglo uses its novel proprietary Cation Exchange Chromatography (CEX) in the manufacturing process for removing FXIa to undetectable levels.

From the CEO: GC Biopharma

“We are pleased to select KabaFusion as a limited distribution partner for Alyglo,” said Woo Jin Lee, chief executive officer of GC Biopharma.
“KabaFusion is an innovative leader and national provider of IVIG specialty pharmacy services. KabaFusion’s national reach, expertise in IVIG, and superb patient management make them an ideal partner.”

From the Founder of KabaFusion

“We are excited about our partnership with GC Biopharma, and KabaFusion is well-positioned to serve a growing number of patients living with primary immunodeficiency. Our nationwide footprint along with our unmatched commitment to deliver high-quality patient care make us a great partner for this important treatment. We are honored to have been chosen as a limited distribution partner for Alyglo,” said Dr. Sohail Masood, founder and CEO of KabaFusion.

GC Biopharma USA, Inc.

GC Biopharma USA, Inc. is headquartered in Teaneck, New Jersey and established its sales, marketing, and business operations in 2018 to serve customers and patients throughout the US.

About KabaFusion

KabaFusion is a national provider of essential chronic and acute infusion therapies.
The company serves patients in 46 states through its nationwide network of home infusion pharmacies, alternative infusion sites, and home health agencies.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!